FOXD2 and thyroid gland carcinoma: In the current study, we found that FOXD2-AS1 was upregulated in thyroid cancer tissues, and high levels of FOXD2-AS1 were positively associated with poor recurrence-free survival in thyroid cancer patients via analyzing thyroid cancer RNA sequencing dataset from The Cancer Genome Atlas (TCGA).